Beihai Gofar Marine Biological Industry Co Ltd (600538) - Net Assets

Latest as of March 2026: CN¥693.82 Million CNY ≈ $101.53 Million USD

Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has net assets worth CN¥693.82 Million CNY (≈ $101.53 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥875.40 Million ≈ $128.10 Million USD) and total liabilities (CN¥181.58 Million ≈ $26.57 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Beihai Gofar Marine Biological Industry tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥693.82 Million
% of Total Assets	79.26%
Annual Growth Rate	7.81%
5-Year Change	-24.04%
10-Year Change	1.74%
Growth Volatility	115.34

Beihai Gofar Marine Biological Industry Co Ltd - Net Assets Trend (1999–2025)

This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's net assets have evolved over time, based on quarterly financial data. See Beihai Gofar Marine Biological Industry liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Beihai Gofar Marine Biological Industry Co Ltd (1999–2025)

The table below shows the annual net assets of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2025. For live valuation and market cap data, see market value of Beihai Gofar Marine Biological Industry .

Year	Net Assets	Change
2025-12-31	CN¥700.78 Million ≈ $102.55 Million	-11.00%
2024-12-31	CN¥787.39 Million ≈ $115.22 Million	-10.45%
2023-12-31	CN¥879.30 Million ≈ $128.67 Million	-8.40%
2022-12-31	CN¥959.98 Million ≈ $140.48 Million	+4.05%
2021-12-31	CN¥922.61 Million ≈ $135.01 Million	+8.34%
2020-12-31	CN¥851.56 Million ≈ $124.61 Million	+31.90%
2019-12-31	CN¥645.61 Million ≈ $94.47 Million	+1.26%
2018-12-31	CN¥637.56 Million ≈ $93.30 Million	-3.28%
2017-12-31	CN¥659.18 Million ≈ $96.46 Million	-4.30%
2016-12-31	CN¥688.79 Million ≈ $100.79 Million	-6.65%
2015-12-31	CN¥737.84 Million ≈ $107.97 Million	+1.13%
2014-12-31	CN¥729.59 Million ≈ $106.76 Million	+554.16%
2013-12-31	CN¥111.53 Million ≈ $16.32 Million	+21.76%
2012-12-31	CN¥91.60 Million ≈ $13.40 Million	-52.20%
2011-12-31	CN¥191.61 Million ≈ $28.04 Million	-15.02%
2010-12-31	CN¥225.47 Million ≈ $32.99 Million	+8.73%
2009-12-31	CN¥207.37 Million ≈ $30.34 Million	-36.28%
2008-12-31	CN¥325.43 Million ≈ $47.62 Million	-33.98%
2007-12-31	CN¥492.89 Million ≈ $72.13 Million	-6.89%
2006-12-31	CN¥529.39 Million ≈ $77.47 Million	-3.98%
2005-12-31	CN¥551.30 Million ≈ $80.67 Million	+5.59%
2004-12-31	CN¥522.14 Million ≈ $76.41 Million	+9.04%
2003-12-31	CN¥478.86 Million ≈ $70.07 Million	+224.58%
2002-12-31	CN¥147.53 Million ≈ $21.59 Million	+13.36%
2001-12-31	CN¥130.15 Million ≈ $19.05 Million	+23.39%
2000-12-31	CN¥105.48 Million ≈ $15.44 Million	+6.42%
1999-12-31	CN¥99.12 Million ≈ $14.50 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Beihai Gofar Marine Biological Industry Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3006.4% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	CN¥1.34 Billion	195.12%
Total Equity	CN¥687.78 Million	100.00%

Beihai Gofar Marine Biological Industry Co Ltd Competitors by Market Cap

The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their market capitalization.

Company	Market Cap
Man Infraconstruction Limited NSE:MANINFRA	$458.25 Million
Xinjiang Winka Times Dept SHG:603101	$458.44 Million
Amex Exploration Inc V:AMX	$458.64 Million
Hangzhou Juheshun New Material Co Ltd SHG:605166	$458.71 Million
Vastned Retail Belgium BR:VASTB	$457.90 Million
PCL Technologies Inc TW:4977	$457.84 Million
USI Corp TW:1304	$457.76 Million
Imricor Medical Systems Inc AU:IMR	$457.57 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Beihai Gofar Marine Biological Industry Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 775,386,925 to 687,776,512, a change of -87,610,413 (-11.3%).
Net loss of 87,621,043 reduced equity.
Dividend payments of 177,911 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥-87.62 Million	-12.74%
Dividends Paid	CN¥177.91K	-0.03%
Other Changes	CN¥188.54K	+0.03%
Total Change	CN¥-	-11.30%

Book Value vs Market Value Analysis

This analysis compares Beihai Gofar Marine Biological Industry Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.55x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 16.37x to 4.55x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1999-12-31	CN¥0.36	CN¥5.97	x
2000-12-31	CN¥0.39	CN¥5.97	x
2001-12-31	CN¥0.48	CN¥5.97	x
2002-12-31	CN¥0.71	CN¥5.97	x
2003-12-31	CN¥2.29	CN¥5.97	x
2004-12-31	CN¥2.41	CN¥5.97	x
2005-12-31	CN¥2.50	CN¥5.97	x
2006-12-31	CN¥1.73	CN¥5.97	x
2007-12-31	CN¥1.84	CN¥5.97	x
2008-12-31	CN¥1.10	CN¥5.97	x
2009-12-31	CN¥0.58	CN¥5.97	x
2010-12-31	CN¥0.65	CN¥5.97	x
2011-12-31	CN¥0.49	CN¥5.97	x
2012-12-31	CN¥0.10	CN¥5.97	x
2013-12-31	CN¥0.17	CN¥5.97	x
2014-12-31	CN¥1.79	CN¥5.97	x
2015-12-31	CN¥1.68	CN¥5.97	x
2016-12-31	CN¥1.43	CN¥5.97	x
2017-12-31	CN¥1.49	CN¥5.97	x
2018-12-31	CN¥1.48	CN¥5.97	x
2019-12-31	CN¥1.34	CN¥5.97	x
2020-12-31	CN¥1.85	CN¥5.97	x
2021-12-31	CN¥1.75	CN¥5.97	x
2022-12-31	CN¥1.91	CN¥5.97	x
2023-12-31	CN¥1.69	CN¥5.97	x
2024-12-31	CN¥1.49	CN¥5.97	x
2025-12-31	CN¥1.31	CN¥5.97	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Beihai Gofar Marine Biological Industry Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -12.74%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -26.69%
• Asset Turnover: 0.37x
• Equity Multiplier: 1.30x
Recent ROE (-12.74%) is above the historical average (-18.38%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1999	16.37%	25.27%	0.38x	1.68x	CN¥6.31 Million
2000	14.89%	19.16%	0.42x	1.87x	CN¥5.13 Million
2001	19.00%	26.15%	0.46x	1.60x	CN¥11.65 Million
2002	16.68%	23.93%	0.42x	1.66x	CN¥9.49 Million
2003	6.15%	12.15%	0.31x	1.62x	CN¥-17.62 Million
2004	3.37%	4.34%	0.36x	2.17x	CN¥-31.87 Million
2005	3.56%	3.84%	0.36x	2.54x	CN¥-32.11 Million
2006	-6.43%	-5.60%	0.41x	2.77x	CN¥-77.22 Million
2007	0.64%	0.38%	0.60x	2.75x	CN¥-44.51 Million
2008	-57.65%	-54.21%	0.27x	3.94x	CN¥-207.36 Million
2009	-86.63%	-57.36%	0.26x	5.90x	CN¥-154.41 Million
2010	9.28%	4.52%	0.51x	4.00x	CN¥-1.27 Million
2011	-28.35%	-7.38%	0.76x	5.06x	CN¥-52.81 Million
2012	-389.29%	-20.18%	0.88x	21.81x	CN¥-112.38 Million
2013	24.03%	2.36%	0.65x	15.53x	CN¥6.24 Million
2014	-7.25%	-11.84%	0.42x	1.46x	CN¥-117.01 Million
2015	0.59%	0.80%	0.51x	1.44x	CN¥-64.17 Million
2016	-4.90%	-12.10%	0.27x	1.47x	CN¥-96.89 Million
2017	1.34%	3.81%	0.30x	1.18x	CN¥-57.07 Million
2018	-3.39%	-9.63%	0.29x	1.20x	CN¥-85.37 Million
2019	0.89%	2.30%	0.33x	1.16x	CN¥-58.79 Million
2020	0.38%	1.20%	0.25x	1.26x	CN¥-81.24 Million
2021	1.14%	2.47%	0.39x	1.18x	CN¥-81.18 Million
2022	3.66%	7.58%	0.40x	1.20x	CN¥-60.31 Million
2023	-9.47%	-22.30%	0.35x	1.21x	CN¥-169.23 Million
2024	-12.10%	-27.57%	0.35x	1.25x	CN¥-171.39 Million
2025	-12.74%	-26.69%	0.37x	1.30x	CN¥-156.40 Million

Industry Comparison

This section compares Beihai Gofar Marine Biological Industry Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.

Industry Context

Industry: Agricultural Inputs
Average net assets among peers: $2,671,873,882
Average return on equity (ROE) among peers: 9.66%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Beihai Gofar Marine Biological Industry Co Ltd (600538)	CN¥693.82 Million	16.37%	0.26x	$457.94 Million
Hubei Yihua Chemical Industry Co Ltd (000422)	$13.55 Billion	6.56%	2.40x	$2.09 Billion
Nanjing Red Sun Co Ltd (000525)	$2.95 Billion	13.14%	1.46x	$831.95 Million
ADAMA Ltd (000553)	$1.12 Billion	2.13%	0.80x	$1.84 Billion
Grand Industrial Holding Co Ltd (000626)	$12.65 Million	0.00%	2.96x	$517.47 Million
Sichuan Meifeng Chemical Industry Co Ltd (000731)	$1.27 Billion	19.58%	0.78x	$440.10 Million
Qinghai Salt Lake Industry Co.Ltd (000792)	$687.57 Million	11.78%	0.49x	$23.04 Billion
Asia Potash International Investment Guangzhou Co Ltd (000893)	$137.96 Million	36.31%	2.09x	$5.53 Billion
Hubei Xinyangfeng Fertilizer Co Ltd (000902)	$417.86 Million	0.76%	1.26x	$2.23 Billion
Sichuan Lutianhua Co Ltd (000912)	$6.38 Billion	1.20%	0.60x	$782.42 Million
Guangxi Hechi Chemical Co Ltd (000953)	$194.14 Million	5.16%	1.04x	$297.88 Million

About Beihai Gofar Marine Biological Industry Co Ltd

SHG:600538 China Agricultural Inputs

Market Cap

$457.94 Million

CN¥3.13 Billion CNY

Market Cap Rank

#12865 Global

#3828 in China

Share Price

CN¥5.97

Change (1 day)

+3.29%

52-Week Range

CN¥5.46 - CN¥7.40

All Time High

CN¥14.86